Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04332094 · UNKNOWN
Trial details
- NCT number
- NCT04332094
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2021-06-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.